Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - haloperidol, quantity: 5 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; calcium hydrogen phosphate dihydrate; acacia; magnesium stearate - chronic therapy: the management of manifestations of psychotic disorders such as schizophrenia, psychosis due to organic brain damageor mental deficiency, senile pyschosis, the manic phase of manic depressive illness, gilles de la tourette syndrome. short term therapy: the treatment of acute alcoholism for the relief of delusions, hallucinations and confused states, and for the control of accompanying tremulousness and aggressive behaviour. in the treatment of intractable nausea and vomiting associated with radiation or malignancy and not responding to other therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - haloperidol, quantity: 10 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; calcium hydrogen phosphate dihydrate; acacia; magnesium stearate - for the control of agitation, hostility, aggressiveness, hallucinationand paranoia associated with acute and chronic psychoses; mania; hypomania; senile dementia; delirium tremens; chorea; severely aggressive and hostile children and for the rare gilles de la tourettesyndrome. for anxiety neurosis; neuroleptanalgesia; as an anti-emetic(except in pregnancy or suspected pregnancy); for radiation sickness as an anti-emetic and anxiolytic in malignant neoplasia (late stage)

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - haloperidol -

Namibia - English - Namibia Medicines Regulatory Council

pfizer laboratories (pty) ltd - haloperidol - injectable solution - 20mg/2ml

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

sumitomo pharma co.,ltd. - haloperidol - colorless and almost limpid solution

Israel - English - Ministry of Health

unipharm ltd, israel - sertraline as hydrochloride - coated tablets - sertraline as hydrochloride 50 mg - sertraline - sertraline - for the treatment of symptoms of depression in patients with or without a history of mania. following satisfactory respose, continuation with sertaline therapy is effective in preventon relapse of the initial episode of depression or recurrence of further depressive episodes.

Israel - English - Ministry of Health

unipharm ltd, israel - sertraline as hydrochloride - coated tablets - sertraline as hydrochloride 100 mg - sertraline - sertraline - for the treatment of symptoms of depression in patients with or without a history of mania. following satisfactory respose, continuation with sertaline therapy is effective in preventon relapse of the initial episode of depression or recurrence of further depressive episodes.

Australia - English - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 47263 - biventricular pacemaker - the medtronic serena quad crt-p mri surescan model w4tr05 dual chamber implantable pulse generator with cardiac resynchronization therapy (crt-p) is a multi-programmable cardiac device that monitors and regulates the patient?s heart rate by providing single or dual chamber rate-responsive bradycardia pacing, sequential biventricular pacing, and atrial tachyarrhythmia therapies. this device features bluetooth wireless technology. the serena quad crt-p mri surescan system is indicated for any of the following types of heart failure patients: ? patients with ventricular dyssynchrony ? patients with reduced ejection fraction (ef), regardless of new york heart association (nyha) class, who are indicated for ventricular pacing, and have high degree av block ? patients with reduced ef and all of the following characteristics: ? have received a conventional pacemaker or an icd ? have subsequently developed worsening heart failure despite optimal medical therapy ? have a high proportion of rv pacing

Australia - English - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 47263 - biventricular pacemaker - the medtronic serena crt-p mri surescan model w1tr05 dual chamber implantable pulse generator with cardiac resynchronization therapy (crt-p) is a multi-programmable cardiac device that monitors and regulates the patient?s heart rate by providing single or dual chamber rate-responsive bradycardia pacing, sequential biventricular pacing, and atrial tachyarrhythmia therapies. this device features bluetooth wireless technology. the serena crt-p mri surescan system is indicated for any of the following types of heart failure patients: ? patients with ventricular dyssynchrony ? patients with reduced ejection fraction (ef), regardless of new york heart association (nyha) class, who are indicated for ventricular pacing, and have high degree av block ? patients with reduced ef and all of the following characteristics: ? have received a conventional pacemaker or an icd ? have subsequently developed worsening heart failure despite optimal medical therapy ? have a high proportion of rv pacing

Australia - English - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 47263 - biventricular pacemaker - the medtronic serena crt-p mri surescan model w1tr05 dual chamber implantable pulse generator with cardiac resynchronization therapy (crt-p) is a multi-programmable cardiac device that monitors and regulates the patient?s heart rate by providing single or dual chamber rate-responsive bradycardia pacing, sequential biventricular pacing, and atrial tachyarrhythmia therapies. this device features bluetooth wireless technology. the serena crt-p mri surescan model w1tr05 system is indicated for heart failure patients who have experienced one or more of the following conditions: ? ventricular dyssynchrony with prolonged qrs ? reduced ejection fraction (ef), regardless of new york heart association (nyha) class, who are indicated for ventricular pacing and have high degree av block ? reduced ef and all of the following characteristics: ? have previously received a conventional pacemaker or an icd ? have subsequently developed worsening heart failure despite optimal medical therapy ? have a high proportion of rv pacing rate adaptive pacing is provided for patients who may benefit from increased pacing rates concurrent with increases in activity. dual chamber and atrial tracking modes are indicated for patients who may benefit from maintenance of av synchrony.